As of 2026-05-12, the Relative Valuation of Sire Bioscience Inc (SIRE.CN) is (0.20) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.37 CAD, the upside of Sire Bioscience Inc based on Relative Valuation is -153.2%.
The range of the Relative Valuation is (0.16) - (0.23) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.3x - 18.4x | 15.4x |
| Forward P/E multiples | 11.5x - 17.3x | 14.4x |
| Fair Price | (0.16) - (0.23) | (0.20) |
| Upside | -143.9% - -161.8% | -153.2% |
| Date | P/E |